Virpax Pharmaceuticals, Inc. (VRPX)
NASDAQ: VRPX · Real-Time Price · USD
0.410
+0.070 (20.59%)
At close: Dec 27, 2024, 4:00 PM
0.501
+0.091 (22.20%)
After-hours: Dec 27, 2024, 7:59 PM EST
Virpax Pharmaceuticals Market Cap
Virpax Pharmaceuticals has a market cap or net worth of $2.00 million as of December 27, 2024. Its market cap has decreased by -54.01% in one year.
Market Cap
2.00M
Enterprise Value
1.83M
1-Year Change
-54.01%
Ranking
Category
Stock Price
$0.41
Market Cap Chart
Since the IPO on February 17, 2021, Virpax Pharmaceuticals's market cap has decreased from $45.09M to $2.00M, a decrease of -95.56%. That is a compound annual growth rate of -55.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 27, 2024 | 2.00M | -46.56% |
| Dec 29, 2023 | 3.75M | -48.56% |
| Dec 30, 2022 | 7.29M | -81.86% |
| Dec 31, 2021 | 40.18M | -10.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| cbdMD | 2.05M |
| Phio Pharmaceuticals | 2.03M |
| Bluejay Diagnostics | 1.99M |
| PainReform | 1.93M |
| TransCode Therapeutics | 1.90M |
| SciSparc | 1.72M |
| Revelation Biosciences | 1.51M |
| China SXT Pharmaceuticals | 1.46M |